Chronic Diseases
Laboratoires Pierre Fabre actively listens to patients to develop innovative therapeutic solutions and support products to care for people affected by a wide range of chronic diseases in urology, women’s health, and rheumatology.
Developing innovative therapeutic solutions in urology
Committed to urology for over 40 years, we are continually innovating to improve patients’ quality of life.
Benign Prostatic Hyperplasia (BPH)
A key player in the treatment of Benign Prostatic Hyperplasia (BPH) since the 1980s, we have developed a plant-based drug that remains one of our flagship products today.
Overactive bladder (OAB)
As part of our commitment to the management of chronic diseases, we launched an innovative treatment for overactive bladder in 2024 across various European countries.
Solutions to support women's health
Since its founding in 1962, Laboratoires Pierre Fabre has been striving to address various needs related to women's health, with a broad portfolio of solutions.
Iron-deficiency anemia
Pierre Fabre was the first to market a drug indicated for iron-deficiency anemia in France. Since then, we have held a leading position, with a 52.1% market share*
Venous insufficiency
The first drug developed by Pierre Fabre in 1959, based on butcher’s broom extracts, was formulated for people suffering from heavy legs. Its commercialisation was a success that continues to this day.
Dysmenorrhea
Naturactive offers a dietary supplement* combining chamomile, which promotes menstrual comfort, and yarrow, which soothes abdominal cramps, with effects felt in less than an hour for 93% of users.
Hormonal well-being
MiYé is the French brand of dermo-cosmetic products and dietary supplements** dedicated to women’s hormonal balance and well-being, from puberty to menopause. Laboratoires Pierre Fabre acquired a stake in the company in 2023.
Always more attentive to patients and consumers
We firmly believe that listening to patients is fundamental to developing increasingly impactful treatments and health products. To provide holistic support throughout the care journey, we support healthcare professionals to empower patients to play a more active role in managing their health.
*In Monthly Theoretical Treatments based on the 12-month year-to-year total ending April 2026 [source: GERS].
**Dietary supplements and dermo-cosmetic products are not a substitute for drug treatments.
